Narayana Hrudayalaya reports 13.5% revenue growth in Q3 FY25 amid healthcare expansion
Narayana Hrudayalaya Limited, one of India’s leading healthcare providers, has reported a 13.5% year-on-year (YoY) increase in consolidated operating revenue, reaching ₹13,667 million for the ... Read More
Burnout crisis explodes: Grant Thornton survey reveals alarming trends
As the workforce landscape evolves amid technological disruption, economic shifts, and changing employee expectations, companies are under pressure to adapt. Grant Thornton, one of the ... Read More
CliniOps and Indegene partner to redefine clinical trial efficiency with digital innovation
CliniOps, a leading innovator in advanced digital clinical trial solutions, has entered into a strategic partnership with Indegene, a digital-first life sciences commercialization company. This ... Read More
Schrödinger stock skyrockets as Novartis invests billions in new partnership
In a landmark development, Schrödinger, Inc. has entered into a multi-target research collaboration and expanded software licensing agreement with Novartis AG, potentially valued at up ... Read More
Centene’s biggest stock drop in years—what’s behind the plunge?
Centene Corporation’s shares experienced their steepest decline in four years, plunging by 7.7% after news of a renewed contract for its subsidiary, Iowa Total Care, ... Read More
Sun Pharma introduces STARIZO to tackle drug-resistant skin infections in India
Sun Pharmaceutical Industries Limited has introduced STARIZO (Tedizolid Phosphate) to the Indian market, a novel antibacterial treatment targeting Acute Bacterial Skin and Skin Structure Infections ... Read More
Lupin Limited secures major victory: A perfect FDA score for its Gujarat plant
Lupin Limited (Lupin), a global pharmaceutical powerhouse, has been awarded the Establishment Inspection Report (EIR) by the United States Food and Drug Administration (U.S. FDA). ... Read More
Strides Pharma Science gets FDA approval for Fluoxetine Tablets for depressive disorders
Strides Pharma Science Limited (Strides) has made a notable advancement in the field of mental health treatment by securing approval from the United States Food ... Read More
Sanofi India partners with Cipla Limited for enhanced distribution of CNS product range
In a strategic move poised to reshape the landscape of Central Nervous System (CNS) medication accessibility in India, Sanofi India Limited (SIL) and Cipla Limited ... Read More
Gilead Sciences completes $4.3bn acquisition of CymaBay Therapeutics to enhance liver disease portfolio
Gilead Sciences, Inc. (Nasdaq: GILD) has officially announced the successful acquisition of CymaBay Therapeutics, Inc. (Nasdaq: CBAY) for a staggering $4.3 billion, a move that ... Read More